Informations générales (source: ClinicalTrials.gov)
This is a Non-interventional, Prospective, Multicenter Study Conducted in France. The Primary Objective of This Study is to Describe the Quality of Life of MS Patients After Initiation of Treatment With Ofatumumab. (SEPROS)
Observational
Novartis Pharmaceuticals (Voir sur ClinicalTrials)
décembre 2023
juillet 2026
05 avril 2025
SEPROS is a non-interventional study, based on primary data collection of MS adult
patients who initiated ofatumumab as per neurologist practice and regardless of the study
protocol.
Etablissements
| Les établissements sans correspondance certaine dans le répertoire FINESS dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| Novartis Investigative Site - 03100 - Montlucon - France | Contact (sur clinicalTrials) | ||||
| Novartis Investigative Site - 13001 - Marseille 01 - France | Contact (sur clinicalTrials) | ||||
| Novartis Investigative Site - 17019 - La Rochelle - France | Contact (sur clinicalTrials) | ||||
| Novartis Investigative Site - 26953 - Valence Cedex 9 - France | Contact (sur clinicalTrials) | ||||
| Novartis Investigative Site - 28630 - Le Coudray - France | Contact (sur clinicalTrials) | ||||
| Novartis Investigative Site - 29200 - Brest - France | Contact (sur clinicalTrials) | ||||
| Novartis Investigative Site - 30029 - Nimes - France | Contact (sur clinicalTrials) | ||||
| Novartis Investigative Site - 31059 - Toulouse Cedex 9 - France | Contact (sur clinicalTrials) | ||||
| Novartis Investigative Site - 33076 - Bordeaux Cedex - France | Contact (sur clinicalTrials) | ||||
| Novartis Investigative Site - 33110 - Le Bouscat - France | Contact (sur clinicalTrials) | ||||
| Novartis Investigative Site - 33505 - Libourne - France | Contact (sur clinicalTrials) | ||||
| Novartis Investigative Site - 34295 - Montpellier - France | Contact (sur clinicalTrials) | ||||
| Novartis Investigative Site - 35043 - Rennes - France | Contact (sur clinicalTrials) | ||||
| Novartis Investigative Site - 37044 - Tours - France | Contact (sur clinicalTrials) | ||||
| Novartis Investigative Site - 40024 - Mont de Marsan cedex - France | Contact (sur clinicalTrials) | ||||
| Novartis Investigative Site - 40107 - Dax - France | Contact (sur clinicalTrials) | ||||
| Novartis Investigative Site - 46000 - Cahors - France | Contact (sur clinicalTrials) | ||||
| Novartis Investigative Site - 47923 - Agen 09 - France | Contact (sur clinicalTrials) | ||||
| Novartis Investigative Site - 49933 - Angers Cedex 9 - France | Contact (sur clinicalTrials) | ||||
| Novartis Investigative Site - 51092 - Reims - France | Contact (sur clinicalTrials) | ||||
| Novartis Investigative Site - 59000 - Lille - France | Contact (sur clinicalTrials) | ||||
| Novartis Investigative Site - 60200 - Compiegne - France | Contact (sur clinicalTrials) | ||||
| Novartis Investigative Site - 62307 - Lens - France | Contact (sur clinicalTrials) | ||||
| Novartis Investigative Site - 62400 - Bethune - France | Contact (sur clinicalTrials) | ||||
| Novartis Investigative Site - 67000 - Strasbourg - France | Contact (sur clinicalTrials) | ||||
| Novartis Investigative Site - 67600 - Selestat - France | Contact (sur clinicalTrials) | ||||
| Novartis Investigative Site - 67700 - Saverne - France | Contact (sur clinicalTrials) | ||||
| Novartis Investigative Site - 68100 - Mulhouse - France | Contact (sur clinicalTrials) | ||||
| Novartis Investigative Site - 68130 - Altkirch - France | Contact (sur clinicalTrials) | ||||
| Novartis Investigative Site - 69100 - Villeurbanne - France | Contact (sur clinicalTrials) | ||||
| Novartis Investigative Site - 69275 - Lyon - France | Contact (sur clinicalTrials) | ||||
| Novartis Investigative Site - 73011 - Chambery cedex - France | Contact (sur clinicalTrials) | ||||
| Novartis Investigative Site - 74130 - Contamine Sur Arve - France | Contact (sur clinicalTrials) | ||||
| Novartis Investigative Site - 74374 - Pringy - France | Contact (sur clinicalTrials) | ||||
| Novartis Investigative Site - 75017 - Paris - France | Contact (sur clinicalTrials) | ||||
| Novartis Investigative Site - 78200 - Mantes La Jolie - France | Contact (sur clinicalTrials) | ||||
| Novartis Investigative Site - 78303 - Poissy - France | Contact (sur clinicalTrials) | ||||
| Novartis Investigative Site - 80054 - Amiens - France | Contact (sur clinicalTrials) | ||||
| Novartis Investigative Site - 83500 - La Seyne Sur Mer - France | Contact (sur clinicalTrials) | ||||
| Novartis Investigative Site - 91400 - Orsay - France | Contact (sur clinicalTrials) | ||||
| Novartis Investigative Site - 94100 - Saint Maur Des Fosses - France | Contact (sur clinicalTrials) | ||||
| Novartis Investigative Site - 97159 - Pointe A Pitre - France | Contact (sur clinicalTrials) | ||||
| Novartis Investigative Site - F-75571 - Paris Cedex 12 - France | Contact (sur clinicalTrials) | ||||
Critères
Tous
Inclusion Criteria:
1. Male or female, 18 years of age or older
2. Patient with confirmed MS diagnosis
3. Patient initiating treatment with ofatumumab for the first time
4. Patient for which the decision to initiate treatment with ofatumumab was made by the
doctor (investigator) in accordance with his/her usual practices independently of
the study
5. Patient not opposed to participation in this study
6. Patient willing and able to complete patient questionnaires
1. Male or female, 18 years of age or older
2. Patient with confirmed MS diagnosis
3. Patient initiating treatment with ofatumumab for the first time
4. Patient for which the decision to initiate treatment with ofatumumab was made by the
doctor (investigator) in accordance with his/her usual practices independently of
the study
5. Patient not opposed to participation in this study
6. Patient willing and able to complete patient questionnaires
1. Patient treated with ofatumumab in the context of a clinical trial